A Study of GEN1106 in Participants with Solid Tumors
GCT1106-01
Phase 1 other active
Quick answer
A Study of GEN1106 in Participants with Solid Tumors for Metastatic or advanced malignant solid tumors is a Phase 1 program (other) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Metastatic or advanced malignant solid tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active